Viridian Therapeutics, Inc. (VRDN)
24.70
-0.10
(-0.40%)
USD |
NASDAQ |
Oct 30, 16:00
25.83
+1.13
(+4.57%)
After-Hours: 20:00
Viridian Therapeutics Cash and Short Term Investments (Annual) : 874.65M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 874.65M |
| December 31, 2024 | 717.58M |
| December 31, 2023 | 477.37M |
| December 31, 2022 | 424.55M |
| December 31, 2021 | 196.96M |
| December 31, 2020 | 127.64M |
| December 31, 2019 | 26.84M |
| Date | Value |
|---|---|
| December 31, 2018 | 62.48M |
| December 31, 2017 | 47.44M |
| December 31, 2016 | 22.10M |
| December 31, 2015 | 10.83M |
| December 31, 2014 | 5.169M |
| December 31, 2013 | 0.2595M |
| December 31, 2012 | 0.1626M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.611B |
| TG Therapeutics, Inc. | 141.97M |
| Travere Therapeutics, Inc. | 322.80M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |